Publications by authors named "B Stemmer"

Article Synopsis
  • Cervical spondylodiscitis is a rare spine infection that affects only a small number of people and can cause serious health problems.
  • The study looked at 24 patients treated for this condition at a hospital from 2017 to 2022, focusing on how severe their cases were.
  • Results showed that many patients had serious complications like sepsis and abscesses, and some sadly passed away, especially those with complicated cases.
View Article and Find Full Text PDF

Introduction: Current treatment of spinal metastases (SM) aims on preserving spinal stability, neurological status, and functional status as well as achieving local control. It consists of spinal surgery followed by radiotherapy and/or systemic treatment. Adjuvant therapy usually starts with a delay of a few weeks to prevent wound healing issues.

View Article and Find Full Text PDF

Background: There is only limited data on the management of cerebrospinal fluid (CSF) fistulas after cervical endoscopic spine surgery. We investigated the current literature for treatment options and present a case of a patient who was treated with CT-guided epidural fibrin patch.

Methods: We present the case of a 47-year-old female patient with a suspected CSF fistula after endoscopic decompression for C7 foraminal stenosis.

View Article and Find Full Text PDF

Background And Aims: The COVID-19 pandemic reached Bavaria in February 2020. Almost simultaneously, Chinese physicians published reports on the first successful treatments with plasma from COVID-19 convalescent donors. With these silver linings on the horizon, we decided to establish the manufacturing of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody-containing plasma from COVID-19 convalescent donors at our site.

View Article and Find Full Text PDF

The ongoing coronavirus disease 2019 (COVID-19) pandemic emerged in December 2019. Convalescent plasma represents a promising COVID-19 treatment. Here, we report on the manufacturing of a plasma-based product containing antibodies specific to SARS-CoV-2 obtained from recently recovered COVID-19 patients.

View Article and Find Full Text PDF